ALIAXIN SR In those cases in which the aim was to restore shape and symmetry combined with a major re-toning effect, ALIAXIN® SR was used. The special feature of this product is the presence of a two-fold effect on the tissues. Thanks to the presence of a gel made up of monophasic hyaluronic acid with 500 kDa, 1000 kDa and 2000 kDa chains, it is possible to achieve an excellent lifting effect of the cutaneous wrinkles and a bio-restructuring effect with the promotion of neocollagenesis. On the other hand, as a result of the presence of 10% natural hyaluronic acid, a significant anti-ageing and hydrating effect is achieved, with maximum results visible in the weeks following treatment. The fluidity of ALIAXIN® SR allows homogeneous diffusion in the tissue, for a therapeutic approach to extended areas of the face, and an increase in the tone, firmness and elasticity of the skin.
ALIAXIN GP In the event of volumetric increases, the dermal filler ALIAXIN® GP was used, made up of highly cross-linked 1000 kDa and 2000 kDa hyaluronic acid-based gel, suitable for the restoration of volume, and to rebuild the areas that have been affected by atrophy. The high level of cross-linking in ALIAXIN® GP increases its duration in the tissues, allowing a significant increase in the volume of the tissues where injected. In the authors’ clinical practice,
ALIAXIN® GP has mainly been used in the cheekbone area and chin, with deep (sub-periosteal) infiltrations. The results obtained were noted as either satisfactory or very
satisfactory in 98 cases, and in only four cases was it necessary to perform a touch-up 2 weeks after the initial treatment. The percentage of side-effects
was not statistically significant with regard to oedema or erythema, which cleared up spontaneously within the first 2 weeks. Follow-up treatments were
performed at 2 weeks, 3 months and 6 months, and in all patients the filling/lifting result obtained in the last follow-up was noticeably maintained, while an improvement in the quality of the cutis treated both in terms of hydration, compactness and texture was also noted.
ALIAXIN® GP for malar zone enhancement, (A) before and (B) after AMWC Symposium
Professor Giuseppe Sito will be presenting at the AMWC Monaco, 2013
HYDROLIFT™ ACTION: A NEW APPROACH IN FACIAL RESHAPING
16:30–17:30, Thursday 4 April Room Ravel, Level -2
“Thanks to the presence of a gel made up of monophasic hyaluronic acid, it is
possible to achieve an excellent lifting effect of the cutaneous wrinkles.
”
prime-journal.com | March 2013 ❚ 113
Conclusions Based on the results achieved when using the ALIAXIN® range of products, it is possible to assert that these dermal fillers are in line with the most reliable hyaluronic acid-based fillers on the market, both in terms of efficacy, safety and durability. This is added to the stimulating biological action of ALIAXIN® SR, which allows the restoration of the collagen structure of the dermis, therefore completing the filling treatment with an anti-ageing action.
Further information
info@viscoderm.com
Please visit us at AMWC Monaco, Ravel Hall, booth M3
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140